Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes
Article in ESC Heart Failure (September 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in ESC Heart Failure (September 2024)
Article in Experimental and Clinical Endocrinology & Diabetes (April 2024)
Article in Die Diabetologie (January 2024)